Symbol="RYTM"
AssetType="Common Stock"
Name="Rhythm Pharmaceuticals Inc"
Description="Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of rare genetic diseases of obesity. The company is headquartered in Boston, Massachusetts."
CIK="1649904"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1540771000"
EBITDA="-178714000"
PERatio="None"
PEGRatio="None"
BookValue="3.204"
DividendPerShare="0"
DividendYield="0"
EPS="-3.3"
RevenuePerShareTTM="0.791"
ProfitMargin="0"
OperatingMarginTTM="-4.124"
ReturnOnAssetsTTM="-0.384"
ReturnOnEquityTTM="-0.964"
RevenueTTM="43765000"
GrossProfitTTM="21505000"
DilutedEPSTTM="-3.3"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.12"
AnalystTargetPrice="38.22"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="95.69"
PriceToBookRatio="5.01"
EVToRevenue="63.85"
EVToEBITDA="-3.718"
Beta="1.686"
num_52WeekHigh="34.99"
num_52WeekLow="15.5"
num_50DayMovingAverage="20.59"
num_200DayMovingAverage="22.46"
SharesOutstanding="58920000"
DividendDate="None"
ExDividendDate="None"
symbol="RYTM"
open="26.12"
high="26.68"
low="25.20"
price="26.15"
volume="240342.00"
latest_trading_day="2023-08-29"
previous_close="26.05"
change="0.10"
change_percent="0.3839%"
aroon_positive_momentum_days="21"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="21"
Volume_recent_avg="734229"
Change_recent_avg="0.08"
Delta_recent_avg="1.0"
Variance_recent_avg="0.5"
Change_ratio_recent_avg="0.28"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="21"
Aroon_momentum_negative="79"
image_negative_thumbnail_id_1="136"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0040.jpeg"
image_negative_thumbnail_id_2="1091"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0124.jpeg"
image_neutral_thumbnail_id_1="565"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0034.jpeg"
image_neutral_thumbnail_id_2="559"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0040.jpeg"
image_positive_thumbnail_id_1="685"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0023.jpeg"
image_positive_thumbnail_id_2="702"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0006.jpeg"
image_professor_thumbnail_id_1="1185"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
image_professor_thumbnail_id_2="1183"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
